Correction: Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1

Correction to: Leukemia

https://doi.org/10.1038/s41375-019-0413-0

Since publication of the original article the authors noticed the affiliation for author G. Martinelli was incorrect. Their correct affiliation is Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy. This has now been corrected in the PDF and HTML versions of this article.

Author information

Correspondence to H. Pfeifer.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Pfeifer, H., Cazzaniga, G., van der Velden, V.H.J. et al. Correction: Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1. Leukemia (2020) doi:10.1038/s41375-020-0707-2

Download citation